Kirsty Hodgson

机构：Clinical Research Institute, University of Newcastle Australia, Newcastle University · ORCID：0000-0003-4348-0430

发表论文 27 篇 · 总被引 406 次 · h-index 11

代表论文

• Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth (2023 · Oncogene · 被引 76)
• ST6GAL1 ‐mediated aberrant sialylation promotes prostate cancer progression (2023 · The Journal of Pathology · 被引 54)
• Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone (2024 · EBioMedicine · 被引 47)
• ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer (2024 · Communications Biology · 被引 38)
• Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome (2019 · Nature Communications · 被引 35)
• Targeting aberrant sialylation and fucosylation in prostate cancer cells using potent metabolic inhibitors (2023 · Glycobiology · 被引 27)